What is DBVT's current stock price?

As of now, DBVT is trading at $19.03, with a daily change of +0.58%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

DBVT Stock Analysis & IQ Rating | DBV Technologies

DBVT DBVT Badge

DBV Technologies

$19.03

+$0.11 | +0.58%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$26.19

MKT CAP

$743.34M

52W Low

$2.93

VOL

$154.73K

P/E Ratio

N/A

AVG VOL

$578.40K

RSI

56.91

TREND

Uptrend

BQ Stock IQ

Login to see DBV Technologies (DBVT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

DBVT Target Price

Login to display

Strengths

DBVT Rewards

Upgraded on attractively valued

DBVT Rewards

Earnings are forecast to grow

DBVT Rewards

Outperform the market

DBVT Price Performance

$12.91 (+47.41%)

$9.94 (+91.45%)

$8.81 (+116.00%)

$5.41 (+251.76%)

1year

6month

3month

1month

DBVT Risk Level

DBVT has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Medium

LOW

HIGH

DBVT Analysts Opinion

DBVT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

DBVT Analysts Opinion

DBVT Analysts opinion is positive and also has improved from the past 3 months

DBVT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

70%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

33%

67%

DBVT Street Sentiment

DBVT Street Sentiment is bullish and have positive views on the near-term outlook

DBVT Performance Sentiment

Sentiments overview associated with DBVT events and the stock performance.

70%

30%

Positive

Negative

19 out of 27
events present

8 out of 27
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$18.92

Resistance
Price

$12.90

Current Price Range

$22.76

Show methods +

DBVT Latest Analysis +

Cantor Fitzgerald Maintains DBV Technologies S.A. - Depositary Receipt (DBVT) Overweight Recommendation. Fintel reports that on December 17 2025 Cantor Fitzgerald maintained coverage of DBV Technologies S.A. - Depositary Receipt (NasdaqCM:DBVT) with a Overweight recommendation. Analyst Price Forecast Suggests 32.15% Downside

Thu Dec 18, 2025

$21.52 | -4.57%

Momentum

Rating

HC Wainwright & Co. Maintains DBV Technologies S.A. - Depositary Receipt (DBVT) Buy Recommendation. Fintel reports that on December 17 2025 HC Wainwright &. Co. maintained coverage of DBV Technologies S.A. - Depositary Receipt (NasdaqCM:DBVT) with a Buy recommendation. Analyst Price Forecast Suggests 32.15% Downside

Thu Dec 18, 2025

$21.52 | -4.57%

Momentum

Rating

Guggenheim Maintains DBV Technologies S.A. - Depositary Receipt (DBVT) Buy Recommendation. Fintel reports that on December 17 2025 Guggenheim maintained coverage of DBV Technologies S.A. - Depositary Receipt (NasdaqCM:DBVT) with a Buy recommendation. Analyst Price Forecast Suggests 32.15% Downside

Thu Dec 18, 2025

$21.52 | -4.57%

Momentum

Rating

Citizens Maintains DBV Technologies S.A. - Depositary Receipt (DBVT) Market Outperform Recommendation. Fintel reports that on December 17 2025 Citizens maintained coverage of DBV Technologies S.A. - Depositary Receipt (NasdaqCM:DBVT) with a Market Outperform recommendation. Analyst Price Forecast Suggests 32.15% Downside

Thu Dec 18, 2025

$21.52 | -4.57%

Momentum

Potential

Rating

DBV Launches Up As Much As 46% On A New Approach To Peanut Allergy. Shares of DBV Technologies launched Wednesday after the company reported promising results for its peanut allergy treatment.The post DBV Launches Up As Much As 46% On A New Approach To Peanut Allergy appeared first on Investor'.s Business Daily.

Wed Dec 17, 2025

$22.55 | +25.42%

Activity

Peanut Allergy Patch For Kids? DBV Technologies Advances Toward FDA Filing. DBVT) on Tuesday released data from the VITESSE Phase 3 study assessing the safety and efficacy of VIASKIN Peanut patch for peanut-allergic children aged 4 to 7 years.DBV Technologies stock is challenging resistance. The pivotal trial .VIASKIN Peanut demonstrated a statistically significant treatment effect with 46.6% of children in the VIASKIN Peanut arm meeting the treatment responder criteria after 12 months as compar

Wed Dec 17, 2025

$22.55 | +25.42%

Activity

DBV Technologies surges on Phase 3 trial win for peanut allergy therapy.

Wed Dec 17, 2025

$22.55 | +25.42%

Momentum

DBVT Soars On Positive Phase 3 Trial Of VIASKIN Peanut Patch . (RTTNews) - DBV Technologies (DBVT) yesterday announced positive topline results from its pivotal Phase 3 VITESSE clinical trial evaluating VIASKIN Peanut patch in children aged 4 to 7 years.

Wed Dec 17, 2025

$22.55 | +25.42%

Activity

Momentum

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years. Châtillon France December 16 2025DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN®. Peanut Patch in Peanut Allergic Children Aged 4-7 Years VITESSE met its primary endpoint: the lower bound of the 95% confidence interval (CI) of the difference between treatment arms was 24.5% exceeding the prespecified th

Tue Dec 16, 2025

$17.98 | -1.64%

Activity

Potential

DBV Technologies stock soars after positive Phase 3 trial results.

Tue Dec 16, 2025

$17.98 | -1.64%

Activity

Momentum

FAQ About DBVT Stock Insights

What is DBVT current stock price?

What are DBVT stock strengths?

What is DBVT Risk Level?

What is DBVT market cap and volume?

What is DBVT current Stock IQ?

Should I buy DBVT stock right now?

Is DBVT a Strong Buy right now?

What does a 'Strong Buy' rating mean for DBVT?

What does a 'Strong Sell' rating mean for DBVT?

What factors influence DBVT's Stock IQ?

Explore our DBVT Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored DBVT Stock Strategies
Effective Risk Management

FIND US ON

Receive our DBVT Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

DBVT DBVT Badge

DBV Technologies

Current Price

$19.03

+$0.11 | +0.58%

52W High

$26.19

MKT CAP

$743.34M

52W Low

$2.93

VOL

$154.73K

P/E Ratio

N/A

AVG VOL

$578.40K

RSI

56.91

TREND

Uptrend

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

DBVT Rewards

Upgraded on attractively valued

DBVT Rewards

Earnings are forecast to grow

DBVT Rewards

Outperform the market

DBVT Price Performance

$12.91 (+47.41%)

$9.94 (+91.45%)

$8.81 (+116.00%)

$5.41 (+251.76%)

1year

6month

3month

1month

DBVT Analysts Opinion

DBVT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

DBVT Analysts Opinion

DBVT Analysts opinion is positive and also has improved from the past 3 months

DBVT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

70%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

33%

67%

DBVT Street Sentiment

DBVT Street Sentiment is bullish and have positive views on the near-term outlook

DBVT Risk Level

DBVT has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Medium

LOW

HIGH

DBVT Performance Sentiment

Sentiments overview associated with DBVT events and the stock performance.

70%

30%

Positive

Negative

19 out of 27
events present

8 out of 27
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$18.92

Resistance
Price

$12.90

Current Price Range

$22.76

Show methods +

DBVT Stock IQ

Login to unlock DBV Technologies (DBVT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

DBVT Latest Analysis

Cantor Fitzgerald Maintains DBV Technologies S.A. - Depositary Receipt (DBVT) Overweight Recommendation. Fintel reports that on December 17 2025 Cantor Fitzgerald maintained coverage of DBV Technologies S.A. - Depositary Receipt (NasdaqCM:DBVT) with a Overweight recommendation. Analyst Price Forecast Suggests 32.15% Downside

Thu Dec 18, 2025

$21.52 | -4.57%

Momentum

Rating

HC Wainwright & Co. Maintains DBV Technologies S.A. - Depositary Receipt (DBVT) Buy Recommendation. Fintel reports that on December 17 2025 HC Wainwright &. Co. maintained coverage of DBV Technologies S.A. - Depositary Receipt (NasdaqCM:DBVT) with a Buy recommendation. Analyst Price Forecast Suggests 32.15% Downside

Thu Dec 18, 2025

$21.52 | -4.57%

Momentum

Rating

Guggenheim Maintains DBV Technologies S.A. - Depositary Receipt (DBVT) Buy Recommendation. Fintel reports that on December 17 2025 Guggenheim maintained coverage of DBV Technologies S.A. - Depositary Receipt (NasdaqCM:DBVT) with a Buy recommendation. Analyst Price Forecast Suggests 32.15% Downside

Thu Dec 18, 2025

$21.52 | -4.57%

Momentum

Rating

Citizens Maintains DBV Technologies S.A. - Depositary Receipt (DBVT) Market Outperform Recommendation. Fintel reports that on December 17 2025 Citizens maintained coverage of DBV Technologies S.A. - Depositary Receipt (NasdaqCM:DBVT) with a Market Outperform recommendation. Analyst Price Forecast Suggests 32.15% Downside

Thu Dec 18, 2025

$21.52 | -4.57%

Momentum

Potential

Rating

DBV Launches Up As Much As 46% On A New Approach To Peanut Allergy. Shares of DBV Technologies launched Wednesday after the company reported promising results for its peanut allergy treatment.The post DBV Launches Up As Much As 46% On A New Approach To Peanut Allergy appeared first on Investor'.s Business Daily.

Wed Dec 17, 2025

$22.55 | +25.42%

Activity

Peanut Allergy Patch For Kids? DBV Technologies Advances Toward FDA Filing. DBVT) on Tuesday released data from the VITESSE Phase 3 study assessing the safety and efficacy of VIASKIN Peanut patch for peanut-allergic children aged 4 to 7 years.DBV Technologies stock is challenging resistance. The pivotal trial .VIASKIN Peanut demonstrated a statistically significant treatment effect with 46.6% of children in the VIASKIN Peanut arm meeting the treatment responder criteria after 12 months as compar

Wed Dec 17, 2025

$22.55 | +25.42%

Activity

DBV Technologies surges on Phase 3 trial win for peanut allergy therapy.

Wed Dec 17, 2025

$22.55 | +25.42%

Momentum

DBVT Soars On Positive Phase 3 Trial Of VIASKIN Peanut Patch . (RTTNews) - DBV Technologies (DBVT) yesterday announced positive topline results from its pivotal Phase 3 VITESSE clinical trial evaluating VIASKIN Peanut patch in children aged 4 to 7 years.

Wed Dec 17, 2025

$22.55 | +25.42%

Activity

Momentum

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years. Châtillon France December 16 2025DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN®. Peanut Patch in Peanut Allergic Children Aged 4-7 Years VITESSE met its primary endpoint: the lower bound of the 95% confidence interval (CI) of the difference between treatment arms was 24.5% exceeding the prespecified th

Tue Dec 16, 2025

$17.98 | -1.64%

Activity

Potential

DBV Technologies stock soars after positive Phase 3 trial results.

Tue Dec 16, 2025

$17.98 | -1.64%

Activity

Momentum

Discover DBVT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of DBVT. We're here to help you make informed investment decisions today.

FIND US ON

Receive our DBVT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

DBVT Stock trends

DBVT Stock performance

DBVT Stock analysis

DBVT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing DBVT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing DBVT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

DBVT Stock Analysis & IQ Rating | DBV Technologies

BQ Stock IQ

DBVT Target Price

DBVT Risk Level

DBVT Analysts Opinion

DBVT Street Sentiment

DBVT Performance Sentiment

Technical Price Levels

Explore our DBVT Stock insights

Receive our DBVT Daily Alerts

DBVT Street Sentiment

DBVT Risk Level

Technical Price Levels

Discover DBVT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of DBVT. We're here to help you make informed investment decisions today.

Receive our DBVT Daily Alerts

DBVT Alerts